Role of the retinal vascular endothelial cell in ocular disease

Progress in Retinal and Eye Research

Volumn 32, Issue 1, 2013, Pages 102-180

  Bharadwaj, Arpita S ^a   Appukuttan, Binoy ^a   Wilmarth, Phillip A ^a   Pan, Yuzhen ^a   Stempel, Andrew J ^a   Chipps, Timothy J ^a   Benedetti, Eric E ^a   Zamora, David O ^a   Choi, Dongseok ^a   David, Larry L ^a   Smith, Justine R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Autoimmune uveitis; Diabetic retinopathy; Endothelial cell; Infectious uveitis; Molecular profiling; Posterior uveitis; Retina; Retinopathy of prematurity

Indexed keywords

ANGIOPOIETIN; CELL PROTEIN; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE CHEMOTACTIC PROTEIN 2; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PROTEOME; SOMATOMEDIN; SUPERVILLIN; TIE RECEPTOR; TOXIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 4;

BLOOD RETINA BARRIER; CELL IMMORTALIZATION; DIABETIC RETINOPATHY; DISEASE PREDISPOSITION; ENDOPHTHALMITIS; EPIGENETICS; EYE PROTECTION; GENE EXPRESSION PROFILING; GENE SEQUENCE; HUMAN; LEUKOCYTE; METABOLOMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRIENT; OXYGEN SUPPLY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEOMICS; RETINA BLOOD VESSEL; RETINA DISEASE; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETINAL VASCULAR ENDOTHELIAL CELL; RETINITIS; RETROLENTAL FIBROPLASIA; REVIEW; TOXOPLASMOSIS; UNINDEXED SEQUENCE; UVEITIS; VISION;

BLOOD-RETINAL BARRIER; ENDOTHELIAL CELLS; HUMANS; RETINA; RETINAL DISEASES; RETINAL VESSELS;

EID: 84871394516     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2012.08.004     Document Type: Review

References (447)

1. Adamis A.P., Shima D.T., Yeo K.T., Yeo T.K., Brown L.F., Berse B., D'Amore P.A., Folkman J. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 1993, 193:631-638.
2. Aguilar E., Dorrell M.I., Friedlander D., Jacobson R.A., Johnson A., Marchetti V., Moreno S.K., Ritter M.R., Friedlander M. Chapter 6. Ocular models of angiogenesis. Meth. Enzymol. 2008, 444:115-158.
3. Ahn J.K., Yu H.G., Chung H., Park Y.G. Intraocular cytokine environment in active Behcet uveitis. Am. J. Ophthalmol. 2006, 142:429-434.
4. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., Pasquale L.R., Thieme H., Iwamoto M.A., Park J.E., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 1994, 331:1480-1487.
5. Aird W.C. Mechanisms of endothelial cell heterogeneity in health and disease. Circ. Res. 2006, 98:159-162.
6. Alessandri G., Raju K., Gullino P.M. Mobilization of capillary endothelium in vitro induced by effectors of angiogenesis in vivo. Cancer Res. 1983, 43:1790-1797.
7. Ameri H., Ratanapakorn T., Rao N.A., Chader G.J., Humayun M.S. Natural course of experimental retinal vein occlusion in rabbit; arterial occlusion following venous photothrombosis. Graefe's Arch. Clin. Exp. Ophthalmol. = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2008, 246:1429-1439.
8. Appukuttan B., McFarland T.J., Davies M.H., Atchaneeyasakul L.O., Zhang Y., Babra B., Pan Y., Rosenbaum J.T., Acott T., Powers M.R., Stout J.T. Identification of novel alternatively spliced isoforms of RTEF-1 within human ocular vascular endothelial cells and murine retina. Invest. Ophthalmol. Vis. Sci. 2007, 48:3775-3782.
9. Appukuttan B., McFarland T.J., Stempel A., Kassem J.B., Hartzell M., Zhang Y., Bond D., West K., Wilson R., Stout A., Pan Y., Ilias H., Robertson K., Klein M.L., Wilson D., Smith J.R., Stout J.T. The related transcriptional enhancer factor-1 isoform, TEAD4(216), can repress vascular endothelial growth factor expression in mammalian cells. PLoS One 2012, 7:e31260.
10. Archer S.K., Behm C.A., Claudianos C., Campbell H.D. The flightless I protein and the gelsolin family in nuclear hormone receptor-mediated signalling. Biochem. Soc. Trans. 2004, 32:940-942.
11. Arocker-Mettinger E., Steurer-Georgiew L., Steurer M., Huber-Spitzy V., Hoelzl E., Grabner G., Kuchar A. Circulating ICAM-1 levels in serum of uveitis patients. Curr. Eye Res. 1992, (11 Suppl.):161-166.
12. Autar A., Faber N., Krabbendam-Peters I., Van Duin R.,G.,E., Van der Giessen W.J., Van Beusekom H.M. Endothelial cell behaviour in response to des drugs shows significant species differences: a comparison of human, swine and rabbit endothelium. Circulation 2011, 124:A12675.
13. Aydintug A.O., Tokgoz G., Ozoran K., Duzgun N., Gurler A., Tutkak H. Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behcet's disease. Rheumatol. Int. 1995, 15:75-78.
14. Bai, H., Inoue, J., Kawano, T., Inazawa, J. A transcriptional variant of the LC3A gene is involved in autophagy and frequently inactivated in human cancers. Oncogene. http://10.1038/onc.2011.613.
15. Baker K.B., Spurrier N.J., Watkins A.S., Smith J.R., Rosenbaum J.T. Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease. Br. J. Ophthalmol. 2006, 90:1481-1485.
16. Banerjee D., Dick A.D. Blocking CD200-CD200 receptor axis augments NOS-2 expression and aggravates experimental autoimmune uveoretinitis in Lewis rats. Ocul. Immunol. Inflamm. 2004, 12:115-125.
17. Baron R.M., Lopez-Guzman S., Riascos D.F., Macias A.A., Layne M.D., Cheng G., Harris C., Chung S.W., Reeves R., von Andrian U.H., Perrella M.A. Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia. PLoS One 2010, 5:e10656.
18. Barragan A., Brossier F., Sibley L.D. Transepithelial migration of Toxoplasma gondii involves an interaction of intercellular adhesion molecule 1 (ICAM-1) with the parasite adhesin MIC2. Cell. Microbiol. 2005, 7:561-568.
19. Barreiro R., Schadlu R., Herndon J., Kaplan H.J., Ferguson T.A. The role of Fas-FasL in the development and treatment of ischemic retinopathy. Invest. Ophthalmol. Vis. Sci. 2003, 44:1282-1286.
20. Becker M.D., Heiligenhaus A., Hudde T., Storch-Hagenlocher B., Wildemann B., Barisani-Asenbauer T., Thimm C., Stubiger N., Trieschmann M., Fiehn C. Interferon as a treatment for uveitis associated with multiple sclerosis. Br. J. Ophthalmol. 2005, 89:1254-1257.
21. Behzadian M.A., Wang X.L., Windsor L.J., Ghaly N., Caldwell R.B. TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function. Invest. Ophthalmol. Vis. Sci. 2001, 42:853-859.
22. Benjamin L.E., Hemo I., Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998, 125:1591-1598.
23. Bishop E.T., Bell G.T., Bloor S., Broom I.J., Hendry N.F., Wheatley D.N. An in vitro model of angiogenesis: basic features. Angiogenesis 1999, 3:335-344.
24. Black M.W., Boothroyd J.C. Lytic cycle of Toxoplasma gondii. Microbiol. Mol. Biol. Rev. 2000, 64:607-623.
25. Bloch-Michel E., Nussenblatt R.B. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am. J. Ophthalmol. 1987, 103:234-235.
26. Bodaghi B., Gendron G., Wechsler B., Terrada C., Cassoux N., Huong du L.T., Lemaitre C., Fradeau C., LeHoang P., Piette J.C. Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients. Br. J. Ophthalmol. 2007, 91:335-339.
27. Bonazzi M., Lecuit M., Cossart P. Listeria monocytogenes internalin and E-cadherin: from structure to pathogenesis. Cell. Microbiol. 2009, 11:693-702.
28. Bonder C.S., Clark S.R., Norman M.U., Johnson P., Kubes P. Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere. Blood 2006, 107:4798-4806.
29. Boulton M., Foreman D., Williams G., McLeod D. VEGF localisation in diabetic retinopathy. Br. J. Ophthalmol. 1998, 82:561-568.
30. Bowden E.T., Coopman P.J., Mueller S.C. Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro. Methods Cell Biol. 2001, 63:613-627.
31. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J. Exp. Med. 1962, 115:453-466.
32. Broderick C., Hoek R.M., Forrester J.V., Liversidge J., Sedgwick J.D., Dick A.D. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am. J. Pathol. 2002, 161:1669-1677.
33. Browning A.C., Halligan E.P., Stewart E.A., Swan D.C., Dove R., Samaranayake G.J., Amoaku W.M. Comparative gene expression profiling of human umbilical vein endothelial cells and ocular vascular endothelial cells. Br. J. Ophthalmol. 2012, 96:128-132.
34. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
35. Brylla E., Tscheudschilsuren G., Santos A.N., Nieber K., Spanel-Borowski K., Aust G. Differences between retinal and choroidal microvascular endothelial cells (MVECs) under normal and hypoxic conditions. Exp. Eye Res. 2003, 77:527-535.
36. Burgos R., Mateo C., Canton A., Hernandez C., Mesa J., Simo R. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Diabetes Care 2000, 23:80-83.
37. Busik J.V., Mohr S., Grant M.B. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 2008, 57:1952-1965.
38. Can G., Ekiz H.A., Baran Y. Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells. Hematology 2011, 16:95-99.
39. Cao R., Jensen L.D., Soll I., Hauptmann G., Cao Y. Hypoxia-induced retinal angiogenesis in zebrafish as a model to study retinopathy. PLoS One 2008, 3:e2748.
40. Carman C.V., Sage P.T., Sciuto T.E., de la Fuente M.A., Geha R.S., Ochs H.D., Dvorak H.F., Dvorak A.M., Springer T.A. Transcellular diapedesis is initiated by invasive podosomes. Immunity 2007, 26:784-797.
41. Carruthers V.B., Hakansson S., Giddings O.K., Sibley L.D. Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment. Infect. Immun. 2000, 68:4005-4011.
42. Caspi R.R., Roberge F.G., Chan C.C., Wiggert B., Chader G.J., Rozenszajn L.A., Lando Z., Nussenblatt R.B. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 1988, 140:1490-1495.
43. Castellon R., Hamdi H.K., Sacerio I., Aoki A.M., Kenney M.C., Ljubimov A.V. Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp. Eye Res. 2002, 74:523-535.
44. Chakravarthy U., Stitt A.W., McNally J., Bailie J.R., Hoey E.M., Duprex P. Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr. Eye Research 1995, 14:285-294.
45. Chan G., Nogalski M.T., Yurochko A.D. Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:22369-22374.
46. Chan-Ling T., McLeod D.S., Hughes S., Baxter L., Chu Y., Hasegawa T., Lutty G.A. Astrocyte-endothelial cell relationships during human retinal vascular development. Invest. Ophthalmol. Vis. Sci. 2004, 45:2020-2032.
47. Chang K.H., Chan-Ling T., McFarland E.L., Afzal A., Pan H., Baxter L.C., Shaw L.C., Caballero S., Sengupta N., Li Calzi S., Sullivan S.M., Grant M.B. IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10595-10600.
48. Chavakis E., Choi E.Y., Chavakis T. Novel aspects in the regulation of the leukocyte adhesion cascade. Thromb. Haemost. 2009, 102:191-197.
49. Chen M., Copland D.A., Zhao J., Liu J., Forrester J.V., Dick A.D., Xu H. Persistent inflammation subverts thrombospondin-1-induced regulation of retinal angiogenesis and is driven by CCR2 ligation. Am. J. Pathol. 2012, 180:235-245.
50. Chen Y., Takizawa N., Crowley J.L., Oh S.W., Gatto C.L., Kambara T., Sato O., Li X.D., Ikebe M., Luna E.J. F-actin and myosin II binding domains in supervillin. J. Biol. Chem. 2003, 278:46094-46106.
51. Cheung N., Mitchell P., Wong T.Y. Diabetic retinopathy. Lancet 2010, 376:124-136.
52. Chhablani J. Fungal endophthalmitis. Expert Rev. Anti Infect. Ther. 2011, 9:1191-1201.
53. Chi J.T., Chang H.Y., Haraldsen G., Jahnsen F.L., Troyanskaya O.G., Chang D.S., Wang Z., Rockson S.G., van de Rijn M., Botstein D., Brown P.O. Endothelial cell diversity revealed by global expression profiling. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10623-10628.
54. Chipps T.J., Streeter P.R., Franc D.T., Neumeyer K., Planck S.R., Rosenbaum J.T., Smith J.R. Modification of the Woodruff-Stamper assay demonstrates binding of Toxoplasma gondii tachyzoites to retinal vascular endothelium. J. Immunol. Methods 2006, 312:209-213.
55. Choi D., Appukuttan B., Binek S.J., Planck S.R., Stout J.T., Rosenbaum J.T., Smith J.R. Prediction of cis-regulatory elements controlling genes differentially expressed by retinal and choroidal vascular endothelial cells. J. Ocul. Biol. Dis. Infor. 2008, 1:37-45.
56. Choo J.K., Seebach J.D., Nickeleit V., Shimizu A., Lei H., Sachs D.H., Madsen J.C. Species differences in the expression of major histocompatibility complex class II antigens on coronary artery endothelium: implications for cell-mediated xenoreactivity. Transplantation 1997, 64:1315-1322.
57. Coleman H.R., Chan C.C., Ferris F.L., Chew E.Y. Age-related macular degeneration. Lancet 2008, 372:1835-1845.
58. Collin H.B. Endothelial cell lined lymphatics in the vascularized rabbit cornea. Invest. Ophthalmol. 1966, 5:337-354.
59. Congdon N.G., Friedman D.S., Lietman T. Important causes of visual impairment in the world today. JAMA 2003, 290:2057-2060.
60. Connor K.M., Krah N.M., Dennison R.J., Aderman C.M., Chen J., Guerin K.I., Sapieha P., Stahl A., Willett K.L., Smith L.E. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat. Protoc. 2009, 4:1565-1573.
61. Copland D.A., Calder C.J., Raveney B.J., Nicholson L.B., Phillips J., Cherwinski H., Jenmalm M., Sedgwick J.D., Dick A.D. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am. J. Pathol. 2007, 171:580-588.
62. Copland D.A., Wertheim M.S., Armitage W.J., Nicholson L.B., Raveney B.J., Dick A.D. The clinical time-course of experimental autoimmune uveoretinitis using topical endoscopic fundal imaging with histologic and cellular infiltrate correlation. Invest. Ophthalmol. Vis. Sci. 2008, 49:5458-5465.
63. Corthals G.L., Wasinger V.C., Hochstrasser D.F., Sanchez J.C. The dynamic range of protein expression: a challenge for proteomic research. Electrophoresis 2000, 21:1104-1115.
64. Courret N., Darche S., Sonigo P., Milon G., Buzoni-Gatel D., Tardieux I. CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 2006, 107:309-316.
65. Crabtree B., Subramanian V. Behavior of endothelial cells on Matrigel and development of a method for a rapid and reproducible in vitro angiogenesis assay. In vitro cellular & developmental biology. Animal 2007, 43:87-94.
66. Crane I.J., Liversidge J. Mechanisms of leukocyte migration across the blood-retina barrier. Semin. Immunopathol. 2008, 30:165-177.
67. Crane I.J., McKillop-Smith S., Wallace C.A., Lamont G.R., Forrester J.V. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 2001, 42:1547-1552.
68. Crane I.J., Wallace C.A., McKillop-Smith S., Forrester J.V. Control of chemokine production at the blood-retina barrier. Immunology 2000, 101:426-433.
69. Crane I.J., Xu H., Wallace C., Manivannan A., Mack M., Liversidge J., Marquez G., Sharp P.F., Forrester J.V. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis. J. Leukoc. Biol. 2006, 79:435-443.
70. Crowley J.L., Smith T.C., Fang Z., Takizawa N., Luna E.J. Supervillin reorganizes the actin cytoskeleton and increases invadopodial efficiency. Mol. Biol. Cell 2009, 20:948-962.
71. Cryotherapy for Retinopathy of Prematurity Cooperative Group Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome-structure and function. Arch. Ophthalmol. 1990, 108:1408-1416.
72. Cunha-Vaz J. The blood-ocular barriers. Surv. Ophthalmol. 1979, 23:279-296.
73. Danis R.P., Bingaman D.P. Insulin-like growth factor-1 retinal microangiopathy in the pig eye. Ophthalmology 1997, 104:1661-1669.
74. Darland D.C., Massingham L.J., Smith S.R., Piek E., Saint-Geniez M., D'Amore P.A. Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev. Biol. 2003, 264:275-288.
75. Darrell R.W., Wagener H.P., Kurland L.T. Epidemiology of uveitis. Incidence and prevalence in a small urban community. Arch. Ophthalmol. 1962, 68:502-514.
76. Das A., Fanslow W., Cerretti D., Warren E., Talarico N., McGuire P. Angiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization. Laboratory investigation. J. Technical Methods Pathol. 2003, 83:1637-1645.
77. Davies M.H., Eubanks J.P., Powers M.R. Increased retinal neovascularization in Fas ligand-deficient mice. Invest. Ophthalmol. Vis. Sci. 2003, 44:3202-3210.
78. DeNiro M., Al-Halafi A., Al-Mohanna F.H., Alsmadi O., Al-Mohanna F.A. Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy. Mol. Pharmacol. 2010, 77:348-367.
79. DeNiro M., Alsmadi O., Al-Mohanna F. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis. Exp. Eye Res. 2009, 89:700-717.
80. Derevjanik N.L., Vinores S.A., Xiao W.H., Mori K., Turon T., Hudish T., Dong S., Campochiaro P.A. Quantitative assessment of the integrity of the blood-retinal barrier in mice. Invest. Ophthalmol. Vis. Sci. 2002, 43:2462-2467.
81. Deuter C.M., Zierhut M., Mohle A., Vonthein R., Stobiger N., Kotter I. Long-term remission after cessation of interferon-alpha treatment in patients with severe uveitis due to Behcet's disease. Arthritis Rheum. 2010, 62:2796-2805.
82. Devi T.S., Singh L.P., Hosoya K., Terasaki T. GSK-3beta/CREB axis mediates IGF-1-induced ECM/adhesion molecule expression, cell cycle progression and monolayer permeability in retinal capillary endothelial cells: implications for diabetic retinopathy. Biochim. Biophys. Acta 2011, 1812:1080-1088.
83. Dick A.D., Broderick C., Forrester J.V., Wright G.J. Distribution of OX2 antigen and OX2 receptor within retina. Invest. Ophthalmol. Vis. Sci. 2001, 42:170-176.
84. Dick A.D., Carter D., Robertson M., Broderick C., Hughes E., Forrester J.V., Liversidge J. Control of myeloid activity during retinal inflammation. J. Leukoc. Biol. 2003, 74:161-166.
85. Dick A.D., Cheng Y.F., Liversidge J., Forrester J.V. Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens. Eye (Lond) 1994, 8(Pt 1):52-59.
86. Dimitroff C.J., Lee J.Y., Rafii S., Fuhlbrigge R.C., Sackstein R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J. Cell Biol. 2001, 153:1277-1286.
87. Dimitroff C.J., Lee J.Y., Schor K.S., Sandmaier B.M., Sackstein R. Differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1. J. Biol. Chem. 2001, 276:47623-47631.
88. Donovan D., Brown N.J., Bishop E.T., Lewis C.E. Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Angiogenesis 2001, 4:113-121.
89. Dorrell M.I., Friedlander M. Mechanisms of endothelial cell guidance and vascular patterning in the developing mouse retina. Prog. Retin. Eye Res. 2006, 25:277-295.
90. Du L., Kijlstra A., Yang P. Immune response genes in uveitis. Ocul. Immunol. Inflamm. 2009, 17:249-256.
91. Dubey J.P., Lindsay D.S., Speer C.A. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev. 1998, 11:267-299.
92. Duguid I.G., Boyd A.W., Mandel T.E. Adhesion molecules are expressed in the human retina and choroid. Curr. Eye Res. 1992, (11 Suppl.):153-159.
93. Early Treatment For Retinopathy Of Prematurity Cooperative, G. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch. Ophthalmol. 2003, 121:1684-1694.
94. El-Remessy A.B., Rajesh M., Mukhopadhyay P., Horvath B., Patel V., Al-Gayyar M.M., Pillai B.A., Pacher P. Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line. Diabetologia 2011, 54:1567-1578.
95. El-Shabrawi Y., Walch A., Hermann J., Egger G., Foster C.S. Inhibition of MMP-dependent chemotaxis and amelioration of experimental autoimmune uveitis with a selective metalloproteinase-2 and -9 inhibitor. J. Neuroimmunol. 2004, 155:13-20.
96. El-Shabrawi Y.G., Christen W.G., Foster S.C. Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1b, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis. Curr. Eye Res. 2000, 20:211-214.
97. Engelhardt B., Wolburg H. Mini-review: transendothelial migration of leukocytes: through the front door or around the side of the house?. Eur. J. Immunol. 2004, 34:2955-2963.
98. Eter N., Sahm M., Klingmuller D., Spitznas M. Modulation of insulin-like growth factor-I production of cultured retinal vascular endothelial cells by oxygen, glucose and growth hormone. Jpn. J. Ophthalmol. 2002, 46:226-229.
99. Fang Z., Takizawa N., Wilson K.A., Smith T.C., Delprato A., Davidson M.W., Lambright D.G., Luna E.J. The membrane-associated protein, supervillin, accelerates F-actin-dependent rapid integrin recycling and cell motility. Traffic (Copenhagen, Denmark) 2010, 11:782-799.
100. Fantin A., Vieira J.M., Gestri G., Denti L., Schwarz Q., Prykhozhij S., Peri F., Wilson S.W., Ruhrberg C. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010, 116:829-840.
101. Fardini Y., Wang X., Temoin S., Nithianantham S., Lee D., Shoham M., Han Y.W. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol. Microbiol. 2011, 82:1468-1480.
102. Feire A.L., Koss H., Compton T. Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:15470-15475.
103. Feng Y., Wang Y., Pfister F., Hillebrands J.L., Deutsch U., Hammes H.P. Decreased hypoxia-induced neovascularization in angiopoietin-2 heterozygous knockout mouse through reduced MMP activity. Cell. Physiol. Biochem. 2009, 23:277-284.
104. Ferrante P., Ramsey A., Bunce C., Lightman S. Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis. Clin. Experiment. Ophthalmol. 2004, 32:563-568.
105. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 2004, 25:581-611.
106. Firth S.M., Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Reviews 2002, 23:824-854.
107. Fong D.S., Girach A., Boney A. Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review. Retina (Philadelphia, Pa) 2007, 27:816-824.
108. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 1996, 16:4604-4613.
109. Franks W.A., Limb G.A., Stanford M.R., Ogilvie J., Wolstencroft R.A., Chignell A.H., Dumonde D.C. Cytokines in human intraocular inflammation. Curr. Eye Res. 1992, (11 Suppl.):187-191.
110. Fruttiger M. Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. Invest. Ophthalmol. Vis. Sci. 2002, 43:522-527.
111. Fruttiger M. Development of the retinal vasculature. Angiogenesis 2007, 10:77-88.
112. Fujikawa L.S., Chan C.C., McAllister C., Gery I., Hooks J.J., Detrick B., Nussenblatt R.B. Retinal vascular endothelium expresses fibronectin and class II histocompatibility complex antigens in experimental autoimmune uveitis. Cell. Immunol. 1987, 106:139-150.
113. Fujikawa L.S., Reay C., Morin M.E. Class II antigens on retinal vascular endothelium, pericytes, macrophages, and lymphocytes of the rat. Invest. Ophthalmol. Vis. Sci. 1989, 30:66-73.
114. Furtado G.C., Cao Y., Joiner K.A. Laminin on Toxoplasma gondii mediates parasite binding to the beta 1 integrin receptor alpha 6 beta 1 on human foreskin fibroblasts and Chinese hamster ovary cells. Infect. Immun. 1992, 60:4925-4931.
115. Furtado, J.M., Bharadwaj, A.S., Chipps, T.J., Pan, Y., Ashander, L.M., Smith, J.R. Toxoplasma gondii tachyzoites cross retinal endothelium assisted by intercellular adhesion molecule-1 in vitro. Immunol. Cell Biol., http://10.1038/icb.2012.21.
116. Gao B.B., Clermont A., Rook S., Fonda S.J., Srinivasan V.J., Wojtkowski M., Fujimoto J.G., Avery R.L., Arrigg P.G., Bursell S.E., Aiello L.P., Feener E.P. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat. Med. 2007, 13:181-188.
117. Gardiner T.A., Stitt A.W., Anderson H.R., Archer D.B. Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs. Br. J. Ophthalmol. 1994, 78:54-60.
118. Gariano R.F. Special features of human retinal angiogenesis. Eye (Lond) 2010, 24:401-407.
119. Garrido-Urbani S., Bradfield P.F., Lee B.P., Imhof B.A. Vascular and epithelial junctions: a barrier for leucocyte migration. Biochem. Soc. Trans. 2008, 36:203-211.
120. Gerhardinger C., McClure K.D., Romeo G., Podesta F., Lorenzi M. IGF-I mRNA and signaling in the diabetic retina. Diabetes 2001, 50:175-183.
121. Gerhardt H. VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 2008, 4:241-246.
122. Gery I., Wiggert B., Redmond T.M., Kuwabara T., Crawford M.A., Vistica B.P., Chader G.J. Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein. Invest. Ophthalmol. Vis. Sci. 1986, 27:1296-1300.
123. Giebel S.J., Menicucci G., McGuire P.G., Das A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab. Invest. 2005, 85:597-607.
124. Gilbert C., Rahi J., Eckstein M., O'Sullivan J., Foster A. Retinopathy of prematurity in middle-income countries. Lancet 1997, 350:12-14.
125. Gillies M.C., Wong T.Y. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 2007, 356:748-749. author reply 749-750.
126. Gordon D.M. Prednisone and prednisolone in ocular disease. Am. J. Ophthalmol. 1956, 41:593-600.
127. Grammas P., Riden M. Retinal endothelial cells are more susceptible to oxidative stress and increased permeability than brain-derived endothelial cells. Microvasc. Res. 2003, 65:18-23.
128. Grant M., Jerdan J., Merimee T.J. Insulin-like growth factor-I modulates endothelial cell chemotaxis. J. Clin. Endocrinol. Metab. 1987, 65:370-371.
129. Grant M.A., Baron R.M., Macias A.A., Layne M.D., Perrella M.A., Rigby A.C. Netropsin improves survival from endotoxaemia by disrupting HMGA1 binding to the NOS2 promoter. Biochem. J. 2009, 418:103-112.
130. Greenwood J., Howes R., Lightman S. The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage. Lab. Invest. 1994, 70:39-52.
131. Greenwood J., Wang Y., Calder V.L. Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off. Immunology 1995, 86:408-415.
132. Greiffenberg L., Goebel W., Kim K.S., Weiglein I., Bubert A., Engelbrecht F., Stins M., Kuhn M. Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: InlB-dependent invasion, long-term intracellular growth, and spread from macrophages to endothelial cells. Infect. Immun. 1998, 66:5260-5267.
133. Gritz D.C., Wong I.G. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 2004, 111:491-500. discussion 500.
134. Grubb S.E., Murdoch C., Sudbery P.E., Saville S.P., Lopez-Ribot J.L., Thornhill M.H. Adhesion of Candida albicans to endothelial cells under physiological conditions of flow. Infect. Immun. 2009, 77:3872-3878.
135. Gudkov A.V., Gurova K.V., Komarova E.A. Inflammation and p53: a tale of two stresses. Genes Cancer 2011, 2:503-516.
136. Gul A., Tugal-Tutkun I., Dinarello C.A., Reznikov L., Esen B.A., Mirza A., Scannon P., Solinger A. Interleukin-1beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. Ann. Rheum. Dis. 2012, 71:563-566.
137. Gustavsson C., Agardh C.D., Zetterqvist A.V., Nilsson J., Agardh E., Gomez M.F. Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia. PLoS One 2010, 5:e12699.
138. Hackett S.F., Ozaki H., Strauss R.W., Wahlin K., Suri C., Maisonpierre P., Yancopoulos G., Campochiaro P.A. Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization. J. Cell. Physiol. 2000, 184:275-284.
139. Hackett S.F., Wiegand S., Yancopoulos G., Campochiaro P.A. Angiopoietin-2 plays an important role in retinal angiogenesis. J. Cell. Physiol. 2002, 192:182-187.
140. Halbert C.L., Demers G.W., Galloway D.A. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 1991, 65:473-478.
141. Hammes H.P., Feng Y., Pfister F., Brownlee M. Diabetic retinopathy: targeting vasoregression. Diabetes 2011, 60:9-16.
142. Harhaj N.S., Felinski, E.A., Wolpert E.B., Sundstrom J.M., Gardner T.W., Antonetti D.A. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest. Ophthalmol. Vis. Sci. 2006, 47:5106-5115.
143. Hartnett M.E. The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model. Doc. Ophthalmol. 2010, 120:25-39.
144. Harvey N.L., Oliver G. Choose your fate: artery, vein or lymphatic vessel?. Curr. Opin. Genet. Dev. 2004, 14:499-505.
145. Hasegawa T., McLeod D.S., Prow T., Merges C., Grebe R., Lutty G.A. Vascular precursors in developing human retina. Invest. Ophthalmol. Vis. Sci. 2008, 49:2178-2192.
146. Hashida N., Ohguro N., Nakai K., Kobashi-Hashida M., Hashimoto S., Matsushima K., Tano Y. Microarray analysis of cytokine and chemokine gene expression after prednisolone treatment in murine experimental autoimmune uveoretinitis. Invest. Ophthalmol. Vis. Sci. 2005, 46:4224-4234.
147. Haurigot V., Villacampa P., Ribera A., Llombart C., Bosch A., Nacher V., Ramos D., Ayuso E., Segovia J.C., Bueren J.A., Ruberte J., Bosch F. Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown. J. Biol. Chem. 2009, 284:22961-22969.
148. Haznedaroglu E., Karaaslan Y., Buyukasik Y., Kosar A., Ozcebe O., Haznedaroglu C., Kirazli E., Dundar S.V. Selectin adhesion molecules in Behcet's disease. Ann. Rheum. Dis. 2000, 59:61-63.
149. Hellstrom A., Perruzzi C., Ju M., Engstrom E., Hard A.L., Liu J.L., Albertsson-Wikland K., Carlsson B., Niklasson A., Sjodell L., LeRoith D., Senger D.R., Smith L.E. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5804-5808.
150. Herwald H. Haemostasis, vascular biology, and infectious agents. Thromb. Haemost. 2007, 98:483-484.
151. Hill T.A., Stanford M.R., Graham E.M., Dumonde D.C., Brown K.A. A new method for studying the selective adherence of blood lymphocytes to the microvasculature of human retina. Invest. Ophthalmol. Vis. Sci. 1997, 38:2608-2618.
152. Hogan M.J., Alvarado J.A., Weddell J.E. Histology of the Human Eye: an Atlas and Textbook 1971, W.B. Saunders Company, Philadelphia.
153. Hogan M.J., Feeney L. The ultrastructure of the retinal vessels. III. Vascular-glial relationships. J. Ultrastruct. Res. 1963, 49:47-64.
154. Holland G.N. Acquired immunodeficiency syndrome and ophthalmology: the first decade. Am. J. Ophthalmol. 1992, 114:86-95.
155. Holland G.N. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am. J. Ophthalmol. 2003, 136:973-988.
156. Holland G.N. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am. J. Ophthalmol. 2004, 137:1-17.
157. Holland G.N., Crespi C.M., Ten Dam-van Loon N., Charonis A.C., Yu F., Bosch-Driessen L.H., Rothova A. Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis. Am. J. Ophthalmol. 2008, 145:1007-1013.
158. Hovakimyan A., Cunningham E.T. Ocular toxoplasmosis. Ophthalmol. Clin. North Am. 2002, 15:327-332.
159. Hughes S., Yang H., Chan-Ling T. Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest. Ophthalmol. Vis. Sci. 2000, 41:1217-1228.
160. Iliaki E., Poulaki V., Mitsiades N., Mitsiades C.S., Miller J.W., Gragoudas E.S. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2009, 50:4898-4904.
161. Im E., Venkatakrishnan A., Kazlauskas A. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol. Biol. Cell 2005, 16:3488-3500.
162. International Committee for the Classification of Retinopathy of Prematurity The international classification of retinopathy of prematurity revisited. Arch. Ophthalmol. 2005, 123:991-999.
163. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., Speed T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
164. Ishida S., Usui T., Yamashiro K., Kaji Y., Amano S., Ogura Y., Hida T., Oguchi Y., Ambati J., Miller J.W., Gragoudas E.S., Ng Y.S., D'Amore P.A., Shima D.T., Adamis A.P. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J. Exp. Med. 2003, 198:483-489.
165. Ishida S., Yamashiro K., Usui T., Kaji Y., Ogura Y., Hida T., Honda Y., Oguchi Y., Adamis A.P. Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease. Nat. Med. 2003, 9:781-788.
166. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., Kaelin W.G. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001, 292:464-468.
167. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A., Hebestreit H.F., Mukherji M., Schofield C.J., Maxwell P.H., Pugh C.W., Ratcliffe P.J. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001, 292:468-472.
168. Jabs D.A. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome-bench to bedside: LXVII Edward Jackson Memorial Lecture. Am. J. Ophthalmol. 2011, 151:198-216 e191.
169. Jabs D.A., Rosenbaum J.T., Foster C.S., Holland G.N., Jaffe G.J., Louie J.S., Nussenblatt R.B., Stiehm E.R., Tessler H., Van Gelder R.N., Whitcup S.M., Yocum D. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am. J. Ophthalmol. 2000, 130:492-513.
170. Jackson T.L., Eykyn S.J., Graham E.M., Stanford M.R. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv. Ophthalmol. 2003, 48:403-423.
171. Jaffe G.J., Martin D., Callanan D., Pearson P.A., Levy B., Comstock T. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology 2006, 113:1020-1027.
172. Jakob E., Reuland M.S., Mackensen F., Harsch N., Fleckenstein M., Lorenz H.M., Max R., Becker M.D. Uveitis subtypes in a German interdisciplinary uveitis center-analysis of 1916 patients. J. Rheumatol. 2009, 36:127-136.
173. Jakobsson L., Franco C.A., Bentley K., Collins R.T., Ponsioen B., Aspalter I.M., Rosewell I., Busse M., Thurston G., Medvinsky A., Schulte-Merker S., Gerhardt H. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat. Cell. Biol. 2010, 12:943-953.
174. Jarvis M.A., Nelson J.A. Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal. J. Virol. 2007, 81:2095-2101.
175. Jin Y., Wu J., Song X., Song Q., Cully B.L., Messmer-Blust A., Xu M., Foo S.Y., Rosenzweig A., Li J. RTEF-1, an upstream gene of hypoxia-inducible factor-1{alpha}, accelerates recovery from ischemia. J. Biol. Chem. 2011, 286:22699-22705.
176. Johnson M.A., Lutty G.A., McLeod D.S., Otsuji T., Flower R.W., Sandagar G., Alexander T., Steidl S.M., Hansen B.C. Ocular structure and function in an aged monkey with spontaneous diabetes mellitus. Exp. Eye Res. 2005, 80:37-42.
177. Jong A.Y., Stins M.F., Huang S.H., Chen S.H., Kim K.S. Traversal of Candida albicans across human blood-brain barrier in vitro. Infect. Immun. 2001, 69:4536-4544.
178. Joussen A.M., Poulaki V., Mitsiades N., Cai W.Y., Suzuma I., Pak J., Ju S.T., Rook S.L., Esser P., Mitsiades C.S., Kirchhof B., Adamis A.P., Aiello L.P. Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. FASEB J. 2003, 17:76-78.
179. Joussen A.M., Poulaki V., Tsujikawa A., Qin W., Qaum T., Xu Q., Moromizato Y., Bursell S.E., Wiegand S.J., Rudge J., Ioffe E., Yancopoulos G.D., Adamis A.P. Suppression of diabetic retinopathy with angiopoietin-1. Am. J. Pathol. 2002, 160:1683-1693.
180. Kalsi K.K., Zych M., Slominska E.M., Kochan Z., Yacoub M.H., Smolenski R.T. Adenine incorporation in human and rat endothelium. Biochim. Biophys. Acta 1999, 1452:145-150.
181. Kanno S., Oda N., Abe M., Terai Y., Ito M., Shitara K., Tabayashi K., Shibuya M., Sato Y. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene 2000, 19:2138-2146.
182. Kanzawa S., Endo H., Shioya N. Improved in vitro angiogenesis model by collagen density reduction and the use of type III collagen. Ann. Plast. Surg. 1993, 30:244-251.
183. Keino H., Takeuchi M., Kezuka T., Yamakawa N., Tsukahara R., Usui M. Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice. Graefe's Arch. Clin. Exp. Ophthalmol. = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2003, 241:111-115.
184. Kempen J.H., Altaweel M.M., Holbrook J.T., Jabs D.A., Louis T.A., Sugar E.A., Thorne J.E. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology 2011, 118:1916-1926.
185. Kempen J.H., O'Colmain B.J., Leske M.C., Haffner S.M., Klein R., Moss S.E., Taylor H.R., Hamman R.F. The prevalence of diabetic retinopathy among adults in the United States. Arch. Ophthalmol. 2004, 122:552-563.
186. Kerr E.C., Copland D.A., Dick A.D., Nicholson L.B. The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis. Prog. Retin. Eye Res. 2008, 27:527-535.
187. Kezic J., McMenamin P.G. The monocyte chemokine receptor CX3CR1 does not play a significant role in the pathogenesis of experimental autoimmune uveoretinitis. Invest. Ophthalmol. Vis. Sci. 2010, 51:5121-5127.
188. Kielczewski J.L., Li Calzi S., Shaw L.C., Cai J., Qi X., Ruan Q., Wu L., Liu L., Hu P., Chan-Ling T., Mames R.N., Firth S., Baxter R.C., Turowski P., Busik J.V., Boulton M.E., Grant M.B. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase). Invest. Ophthalmol. Vis. Sci. 2011, 52:8278-8286.
189. Kim K.J., Chung J.W., Kim K.S. 67-kDa laminin receptor promotes internalization of cytotoxic necrotizing factor 1-expressing Escherichia coli K1 into human brain microvascular endothelial cells. J. Biol. Chem. 2005, 280:1360-1368.
190. Kim K.S. E. coli invasion of brain microvascular endothelial cells as a pathogenetic basis of meningitis. Subcell. Biochem. 2000, 33:47-59.
191. Kim K.S. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat. Rev. Neurosci. 2003, 4:376-385.
192. Kim S.Y., Johnson M.A., McLeod D.S., Alexander T., Hansen B.C., Lutty G.A. Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas. Diabetes 2005, 54:1534-1542.
193. King G.L., Goodman A.D., Buzney S., Moses A., Kahn C.R. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J. Clin. Invest. 1985, 75:1028-1036.
194. King H., Aubert R.E., Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21:1414-1431.
195. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995, 86:1243-1254.
196. Kitamei H., Iwabuchi K., Namba K., Yoshida K., Yanagawa Y., Kitaichi N., Kitamura M., Ohno S., Onoe K. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate. J. Leukoc. Biol. 2006, 79:1193-1201.
197. Knight B.C., Brunton C.L., Modi N.C., Wallace G.R., Stanford M.R. The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells. J. Neuroimmunol. 2005, 160:41-47.
198. Knott R.M., Robertson M., Muckersie E., Folefac V.A., Fairhurst F.E., Wileman S.M., Forrester J.V. A model system for the study of human retinal angiogenesis: activation of monocytes and endothelial cells and the association with the expression of the monocarboxylate transporter type 1 (MCT-1). Diabetologia 1999, 42:870-877.
199. Kociok N., Radetzky S., Krohne T.U., Gavranic C., Liang Y., Semkova I., Joussen A.M. ICAM-1 depletion does not alter retinal vascular development in a model of oxygen-mediated neovascularization. Exp. Eye Res. 2009, 89:503-510.
200. Kok H., Lau C., Maycock N., McCluskey P., Lightman S. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology 2005, 112(1916):e1911-1917.
201. Kotter I., Koch S., Vonthein R., Ruckwaldt U., Amberger M., Gunaydin I., Zierhut M., Stubiger N. Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behcet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. Clin. Exp. Rheumatol. 2005, 23:S20-S26.
202. Kowluru R.A., Koppolu P. Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Radic. Res. 2002, 36:993-999.
203. Kozulin P., Natoli R., Bumsted O'Brien K.M., Madigan M.C., Provis J.M. The cellular expression of antiangiogenic factors in fetal primate macula. Invest. Ophthalmol. Vis. Sci. 2010, 51:4298-4306.
204. Kozulin P., Natoli R., Madigan M.C., O'Brien K.M., Provis J.M. Gradients of Eph-A6 expression in primate retina suggest roles in both vascular and axon guidance. Mol. Vis. 2009, 15:2649-2662.
205. Kozulin P., Natoli R., O'Brien K.M., Madigan M.C., Provis J.M. Differential expression of anti-angiogenic factors and guidance genes in the developing macula. Mol. Vis. 2009, 15:45-59.
206. Kramer R.H., Cheng Y.F., Clyman R. Human microvascular endothelial cells use beta 1 and beta 3 integrin receptor complexes to attach to laminin. J. Cell Biol. 1990, 111:1233-1243.
207. Krebs D.L., Hilton D.J. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 2001, 19:378-387.
208. Kremer I., Kissun R., Nissenkorn I., Ben-Sira I., Garner A. Oxygen-induced retinopathy in newborn kittens. A model for ischemic vasoproliferative retinopathy. Invest. Ophthalmol. Vis. Sci. 1987, 28:126-130.
209. Kroemer G., Marino G., Levine B. Autophagy and the integrated stress response. Mol. Cell 2010, 40:280-293.
210. Kuiper J.J., Mutis T., de Jager W., de Groot-Mijnes J.D., Rothova A. Intraocular interleukin-17 and proinflammatory cytokines in HLA-A29-associated birdshot chorioretinopathy. Am. J. Ophthalmol. 2011, 152:177-182 e171.
211. Kuppner M.C., Liversidge J., McKillop-Smith S., Lumsden L., Forrester J.V. Adhesion molecule expression in acute and fibrotic sympathetic ophthalmia. Curr. Eye Res. 1993, 12:923-934.
212. Lagarkova M.A., Shutova M.V., Bogomazova A.N., Vassina E.M., Glazov E.A., Zhang P., Rizvanov A.A., Chestkov I.V., Kiselev S.L. Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale. Cell Cycle 2010, 9:937-946.
213. Lambert H., Hitziger N., Dellacasa I., Svensson M., Barragan A. Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell. Microbiol. 2006, 8:1611-1623.
214. Lanigan L.P., Birche R., Clark C.V., Hill D.W. The effect of cervical sympathectomy on retinal vessel responses to systemic autonomic stimulation. Eye (Lond) 1990, 4(Pt 1):181-189.
215. Lawley T.J., Kubota Y. Induction of morphologic differentiation of endothelial cells in culture. J. Invest. Dermatol. 1989, 93:59S-61S.
216. Lawrenson J.G., Cassella J.P., Hayes A.J., Firth J.A., Allt G. Endothelial glycoconjugates: a comparative lectin study of the brain, retina and myocardium. J. Anat. 2000, 196(Pt 1):55-60.
217. Leal E.C., Aveleira C.A., Castilho A.F., Serra A.M., Baptista F.I., Hosoya K., Forrester J.V., Ambrosio A.F. High glucose and oxidative/nitrosative stress conditions induce apoptosis in retinal endothelial cells by a caspase-independent pathway. Exp. Eye Res. 2009, 88:983-991.
218. Lebherz C., Maguire A.M., Auricchio A., Tang W., Aleman T.S., Wei Z., Grant R., Cideciyan A.V., Jacobson S.G., Wilson J.M., Bennett J. Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor. Diabetes 2005, 54:1141-1149.
219. Lee M.T., Hooper L.C., Kump L., Hayashi K., Nussenblatt R., Hooks J.J., Detrick B. Interferon-beta and adhesion molecules (E-selectin and s-intracellular adhesion molecule-1) are detected in sera from patients with retinal vasculitis and are induced in retinal vascular endothelial cells by Toll-like receptor 3 signalling. Clin. Exp. Immunol. 2007, 147:71-80.
220. Levy A.P., Levy N.S., Wegner S., Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 1995, 270:13333-13340.
221. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7:678-689.
222. Li C., Wong W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:31-36.
223. Li H., Yoneda M., Takeyama M., Sugita I., Tsunekawa H., Yamada H., Watanabe D., Mukai T., Yamamura M., Iwaki M., Zako M. Effect of infliximab on tumor necrosis factor-alpha-induced alterations in retinal microvascular endothelial cells and retinal pigment epithelial cells. J. Ocul. Pharmacol. Ther. 2010, 26:549-556.
224. Lim J.I., Spee C., Hinton D.R. A comparison of hypoxia-inducible factor-alpha in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients. Retina (Philadelphia, Pa) 2010, 30:1472-1478.
225. Link A.J., Eng J., Schieltz D.M., Carmack E., Mize G.J., Morris D.R., Garvik B.M., Yates J.R. Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 1999, 17:676-682.
226. Linsenmeier R.A., Braun R.D., McRipley M.A., Padnick L.B., Ahmed J., Hatchell D.L., McLeod D.S., Lutty G.A. Retinal hypoxia in long-term diabetic cats. Invest. Ophthalmol. Vis. Sci. 1998, 39:1647-1657.
227. Liu H., Sadygov R.G., Yates J.R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 76:4193-4201.
228. Liu H.P., Yu M.C., Jiang M.H., Chen J.X., Yan D.P., Liu F., Ge B.X. Association of supervillin with KIR2DL1 regulates the inhibitory signaling of natural killer cells. Cell Signal. 2011, 23:487-496.
229. Liversidge J., Dick A., Gordon S. Nitric oxide mediates apoptosis through formation of peroxynitrite and Fas/Fas-ligand interactions in experimental autoimmune uveitis. Am. J. Pathol. 2002, 160:905-916.
230. Liversidge J., Sewell H.F., Forrester J.V. Interactions between lymphocytes and cells of the blood-retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro. Immunology 1990, 71:390-396.
231. Lofqvist C., Chen J., Connor K.M., Smith A.C., Aderman C.M., Liu N., Pintar J.E., Ludwig T., Hellstrom A., Smith L.E. IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10589-10594.
232. Lofqvist C., Willett K.L., Aspegren O., Smith A.C., Aderman C.M., Connor K.M., Chen J., Hellstrom A., Smith L.E. Quantification and localization of the IGF/insulin system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in mice. Invest. Ophthalmol. Vis. Sci. 2009, 50:1831-1837.
233. London N.J., Rathinam S.R., Cunningham E.T. The epidemiology of uveitis in developing countries. Int. Ophthalmol. Clin. 2010, 50:1-17.
234. Lowder C., Belfort R., Lightman S., Foster C.S., Robinson M.R., Schiffman R.M., Li X.Y., Cui H., Whitcup S.M. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch. Ophthalmol. 2011, 129:545-553.
235. Lowe W.L., Florkiewicz R.Z., Yorek M.A., Spanheimer R.G., Albrecht B.N. Regulation of growth factor mRNA levels in the eyes of diabetic rats. Metabolism 1995, 44:1038.
236. Lowenstein C.J., Dinerman J.L., Snyder S.H. Nitric oxide: a physiologic messenger. Ann. Intern. Med. 1994, 120:227-237.
237. Lu M., Perez V.L., Ma N., Miyamoto K., Peng H.B., Liao J.K., Adamis A.P. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest. Ophthalmol. Vis. Sci. 1999, 40:1808-1812.
238. Luger D., Caspi R.R. New perspectives on effector mechanisms in uveitis. Semin. Immunopathol. 2008, 30:135-143.
239. Luger D., Silver P.B., Tang J., Cua D., Chen Z., Iwakura Y., Bowman E.P., Sgambellone N.M., Chan C.C., Caspi R.R. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 2008, 205:799-810.
240. Luna J.D., Chan C.C., Derevjanik N.L., Mahlow J., Chiu C., Peng B., Tobe T., Campochiaro P.A., Vinores S.A. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J. Neurosci. Res. 1997, 49:268-280.
241. Lutty G.A., McLeod D.S., Merges C., Diggs A., Plouet J. Localization of vascular endothelial growth factor in human retina and choroid. Arch. Ophthalmol. 1996, 114:971-977.
242. Luz-Madrigal A., Clapp C., Aranda J., Vaca L. In vivo transcriptional targeting into the retinal vasculature using recombinant baculovirus carrying the human flt-1 promoter. Virol. J. 2007, 4:88.
243. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., Compton D., McClain J., Aldrich T.H., Papadopoulos N., Daly T.J., Davis S., Sato T.N., Yancopoulos G.D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60.
244. Manalo D.J., Rowan A., Lavoie T., Natarajan L., Kelly B.D., Ye S.Q., Garcia J.G., Semenza G.L. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005, 105:659-669.
245. Martin A.P., de Moraes L.V., Tadokoro C.E., Commodaro A.G., Urrets-Zavalia E., Rabinovich G.A., Urrets-Zavalia J., Rizzo L.V., Serra H.M. Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 2005, 46:2056-2063.
246. Martin J.L., Baxter R.C. Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3. Growth Factors 2011, 29:235-244.
247. Matsusaka T. Tridimensional views of the relationship of pericytes to endothelial cells of capillaries in the human choroid and retina. J. Electron. Microsc. (Tokyo) 1975, 24:13-18.
248. McCawley L.J., Matrisian L.M. Matrix metalloproteinases: they're not just for matrix anymore!. Curr. Opin. Cell Biol. 2001, 13:534-540.
249. McLeod D.S., D'Anna S.A., Lutty G.A. Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy. Invest. Ophthalmol. Vis. Sci. 1998, 39:1918-1932.
250. McLeod D.S., Hasegawa T., Prow T., Merges C., Lutty G. The initial fetal human retinal vasculature develops by vasculogenesis. Dev. Dyn. 2006, 235:3336-3347.
251. McLeod D.S., Lefer D.J., Merges C., Lutty G.A. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am. J. Pathol. 1995, 147:642-653.
252. McLoone E., O'Keefe M., McLoone S., Lanigan B. Long term functional and structural outcomes of laser therapy for retinopathy of prematurity. Br. J. Ophthalmol. 2006, 90:754-759.
253. McMenamin P.G., Forrester J.V., Steptoe R.J., Dua H.S. Ultrastructural pathology of experimental autoimmune uveitis. Quantitative evidence of activation and possible high endothelial venule-like changes in retinal vascular endothelium. Lab. Invest. 1992, 67:42-55.
254. Menage M.J., Robinson J.C., Kaufman P.L., Sponsel W.E. Retinal blood flow after superior cervical ganglionectomy: a laser Doppler study in the cynomolgus monkey. Br. J. Ophthalmol. 1994, 78:49-53.
255. Mendrinos E., Petropoulos I.K., Mangioris G., Tsilimbaris M.K., Papadopoulou D.N., Geka A., Pournaras C.J. Vasomotor effect of intravitreal juxta-arteriolar injection of L-lactate on the retinal arterioles after acute branch retinal vein occlusion in minipigs. Invest. Ophthalmol. Vis. Sci. 2011, 52:3215-3220.
256. Meyer-Schwickerath R., Pfeiffer A., Blum W.F., Freyberger H., Klein M., Losche C., Rollmann R., Schatz H. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J. Clin. Invest. 1993, 92:2620-2625.
257. Micieli J.A., Surkont M., Smith A.F. A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity. Am. J. Ophthalmol. 2009, 148:536-543 e532.
258. Middleton J., Patterson A.M., Gardner L., Schmutz C., Ashton B.A. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 2002, 100:3853-3860.
259. Miyamoto K., Khosrof S., Bursell S.E., Rohan R., Murata T., Clermont A.C., Aiello L.P., Ogura Y., Adamis A.P. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10836-10841.
260. Miyamoto N., Mandai M., Takagi H., Suzuma I., Suzuma K., Koyama S., Otani A., Oh H., Honda Y. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP. Invest. Ophthalmol. Vis. Sci. 2002, 43:2007-2014.
261. Mohr S., Xi X., Tang J., Kern T.S. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 2002, 51:1172-1179.
262. Monteiro V.G., Soares C.P., de Souza W. Host cell surface sialic acid residues are involved on the process of penetration of Toxoplasma gondii into mammalian cells. FEMS Microbiol. Lett. 1998, 164:323-327.
263. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
264. Montoya J.G., Remington J.S. Toxoplasmosis of the central nervous system. Defense of the Brain: Current Concepts in the Immunopathogenesis and Clinical Aspects of CNS Infections 1997, Blackwell Scientific, Boston. P.K. Peterson, J.S. Remington (Eds.).
265. Motiejunaite R., Kazlauskas A. Pericytes and ocular diseases. Exp. Eye Res. 2008, 86:171-177.
266. Mowat F.M., Luhmann U.F., Smith A.J., Lange C., Duran Y., Harten S., Shukla D., Maxwell P.H., Ali R.R., Bainbridge J.W. HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia. PLoS One 2010, 5:e11103.
267. Nagineni C.N., Detrick B., Hooks J.J. Transforming growth factor-beta expression in human retinal pigment epithelial cells is enhanced by Toxoplasma gondii: a possible role in the immunopathogenesis of retinochoroiditis. Clin. Exp. Immunol. 2002, 128:372-378.
268. Naito Y., Yamada T., Ui-Tei K., Morishita S., Saigo K. siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. Nucleic Acids Res. 2004, 32:W124-W129.
269. Nambu H., Nambu R., Oshima Y., Hackett S.F., Okoye G., Wiegand S., Yancopoulos G., Zack D.J., Campochiaro P.A. Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier. Gene Ther. 2004, 11:865-873.
270. Nambu H., Umeda N., Kachi S., Oshima Y., Akiyama H., Nambu R., Campochiaro P.A. Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization. J. Cell. Physiol. 2005, 204:227-235.
271. Nguyen A.M., Rao N.A. Oxidative photoreceptor cell damage in autoimmune uveitis. J. Ophthalmic Inflamm. Infect. 2011, 1:7-13.
272. Noda K., Nakao S., Ishida S., Ishibashi T. Leukocyte adhesion molecules in diabetic retinopathy. J. Ophthalmol. 2012, 2012:279037.
273. Nourshargh S., Hordijk P.L., Sixt M. Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat. Rev. Mol. Cell. Biol. 2010, 11:366-378.
274. Nussenblatt R.B. The natural history of uveitis. Int. Ophthalmol. 1990, 14:303-308.
275. Nussenblatt R.B. Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Invest. Ophthalmol. Vis. Sci. 1991, 32:3131-3141.
276. Oh H., Takagi H., Suzuma K., Otani A., Matsumura M., Honda Y. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J. Biol. Chem. 1999, 274:15732-15739.
277. Oh H.M., Yu C.R., Lee Y., Chan C.C., Maminishkis A., Egwuagu C.E. Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms. J. Immunol. 2011, 187:3338-3346.
278. Oh S.W., Pope R.K., Smith K.P., Crowley J.L., Nebl T., Lawrence J.B., Luna E.J. Archvillin, a muscle-specific isoform of supervillin, is an early expressed component of the costameric membrane skeleton. J. Cell. Sci. 2003, 116:2261-2275.
279. Ohashi H., Takagi H., Koyama S., Oh H., Watanabe D., Antonetti D.A., Matsubara T., Nagai K., Arai H., Kita T., Honda Y. Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic rats. Mol. Vis. 2004, 10:608-617.
280. Ohno-Matsui K., Hirose A., Yamamoto S., Saikia J., Okamoto N., Gehlbach P., Duh E.J., Hackett S., Chang M., Bok D., Zack D.J., Campochiaro P.A. Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am. J. Pathol. 2002, 160:711-719.
281. Okada A.A., Keino H., Fukai T., Sakai J., Usui M., Mizuguchi J. Effect of type I interferon on experimental autoimmune uveoretinitis in rats. Ocul. Immunol. Inflamm. 1998, 6:215-226.
282. Okada A.A., Keino H., Suzuki J., Sakai J., Usui M., Mizuguchi J. Kinetics of intraocular cytokines in the suppression of experimental autoimmune uveoretinitis by type I IFN. Int. Immunol. 1998, 10:1917-1922.
283. Olson J.A., Whitelaw C.M., McHardy K.C., Pearson D.W., Forrester J.V. Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia 1997, 40:1166-1171.
284. Ortega-Barria E., Boothroyd J.C. A Toxoplasma lectin-like activity specific for sulfated polysaccharides is involved in host cell infection. J. Biol. Chem. 1999, 274:1267-1276.
285. Oshima Y., Oshima S., Nambu H., Kachi S., Takahashi K., Umeda N., Shen J., Dong A., Apte R.S., Duh E., Hackett S.F., Okoye G., Ishibashi K., Handa J., Melia M., Wiegand S., Yancopoulos G., Zack D.J., Campochiaro P.A. Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive. FASEB J. 2005, 19:963-965.
286. Otrock Z.K., Makarem J.A., Shamseddine A.I. Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol. Dis. 2007, 38:258-268.
287. Ottino P., Finley J., Rojo E., Ottlecz A., Lambrou G.N., Bazan H.E., Bazan N.G. Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: involvement of cytosolic phospholipase A2 activity. Mol. Vis. 2004, 10:341-350.
288. Ozaki H., Yu A.Y., Della N., Ozaki K., Luna J.D., Yamada H., Hackett S.F., Okamoto N., Zack D.J., Semenza G.L., Campochiaro P.A. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest. Ophthalmol. Vis. Sci. 1999, 40:182-189.
289. Ozsolak F., Milos P.M. RNA sequencing: advances, challenges and opportunities. Nat. Rev. Genet. 2011, 12:87-98.
290. Pan J., Xia L., McEver R.P. Comparison of promoters for the murine and human P-selectin genes suggests species-specific and conserved mechanisms for transcriptional regulation in endothelial cells. J. Biol. Chem. 1998, 273:10058-10067.
291. Papachristodoulou D., Heath H., Kang S.S. The development of retinopathy in sucrose-fed and streptozotocin-diabetic rats. Diabetologia 1976, 12:367-374.
292. Paques M., Guyomard J.L., Simonutti M., Roux M.J., Picaud S., Legargasson J.F., Sahel J.A. Panretinal, high-resolution color photography of the mouse fundus. Invest. Ophthalmol. Vis. Sci. 2007, 48:2769-2774.
293. Parikh J.G., Saraswathy S., Rao N.A. Photoreceptor oxidative damage in sympathetic ophthalmia. Am. J. Ophthalmol. 2008, 146:866-875 e862.
294. Parnaby-Price A., Stanford M.R., Biggerstaff J., Howe L., Whiston R.A., Marshall J., Wallace G.R. Leukocyte trafficking in experimental autoimmune uveitis in vivo. J. Leukoc. Biol. 1998, 64:434-440.
295. Pasqualini R., Moeller B.J., Arap W. Leveraging molecular heterogeneity of the vascular endothelium for targeted drug delivery and imaging. Semin. Thromb. Hemost. 2010, 36:343-351.
296. Pavesio C., Zierhut M., Bairi K., Comstock T.L., Usner D.W. Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. Ophthalmology 2010, 117:567-575. 575.e1.
297. Pellieux C., Desgeorges A., Pigeon C.H., Chambaz C., Yin H., Hayoz D., Silacci P. Cap G, a gelsolin family protein modulating protective effects of unidirectional shear stress. J. Biol. Chem. 2003, 278:29136-29144.
298. Penn J.S., Tolman B.L., Lowery L.A. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest. Ophthalmol. Vis. Sci. 1993, 34:576-585.
299. Pestonjamasp K.N., Pope R.K., Wulfkuhle J.D., Luna E.J. Supervillin (p205): a novel membrane-associated, F-actin-binding protein in the villin/gelsolin superfamily. J. Cell Biol. 1997, 139:1255-1269.
300. Peters S., Cree I.A., Alexander R., Turowski P., Ockrim Z., Patel J., Boyd S.R., Joussen A.M., Ziemssen F., Hykin P.G., Moss S.E. Angiopoietin modulation of vascular endothelial growth factor: effects on retinal endothelial cell permeability. Cytokine 2007, 40:144-150.
301. Pfister F., Feng Y., vom Hagen F., Hoffmann S., Molema G., Hillebrands J.L., Shani M., Deutsch U., Hammes H.P. Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes 2008, 57:2495-2502.
302. Phan Q.T., Fratti R.A., Prasadarao N.V., Edwards J.E., Filler S.G. N-cadherin mediates endocytosis of Candida albicans by endothelial cells. J. Biol. Chem. 2005, 280:10455-10461.
303. Pope R.K., Pestonjamasp K.N., Smith K.P., Wulfkuhle J.D., Strassel C.P., Lawrence J.B., Luna E.J. Cloning, characterization, and chromosomal localization of human superillin (SVIL). Genomics 1998, 52:342-351.
304. Poulaki V., Joussen A.M., Mitsiades N., Mitsiades C.S., Iliaki E.F., Adamis A.P. Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am. J. Pathol. 2004, 165:457-469.
305. Poulaki V., Qin W., Joussen A.M., Hurlbut P., Wiegand S.J., Rudge J., Yancopoulos G.D., Adamis A.P. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J. Clin. Invest. 2002, 109:805-815.
306. Pournaras C.J., Rungger-Brandle E., Riva C.E., Hardarson S.H., Stefansson E. Regulation of retinal blood flow in health and disease. Prog. Retin. Eye Res. 2008, 27:284-330.
307. Prasadarao N.V., Srivastava P.K., Rudrabhatla R.S., Kim K.S., Huang S.H., Sukumaran S.K. Cloning and expression of the Escherichia coli K1 outer membrane protein A receptor, a gp96 homologue. Infect. Immun. 2003, 71:1680-1688.
308. Qiu Y., Hoareau-Aveilla C., Oltean S., Harper S.J., Bates D.O. The anti-angiogenic isoforms of VEGF in health and disease. Biochem. Soc. Trans. 2009, 37:1207-1213.
309. Quillen D.A., Davis J.B., Gottlieb J.L., Blodi B.A., Callanan D.G., Chang T.S., Equi R.A. The white dot syndromes. Am. J. Ophthalmol. 2004, 137:538-550.
310. Rajendram R., Saraswathy S., Rao N.A. Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis. Br. J. Ophthalmol. 2007, 91:531-537.
311. Rakoczy E.P., Ali Rahman I.S., Binz N., Li C.R., Vagaja N.N., de Pinho M., Lai C.M. Characterization of a mouse model of hyperglycemia and retinal neovascularization. Am. J. Pathol. 2010, 177:2659-2670.
312. Rakoczy P.E., Brankov M., Fonceca A., Zaknich T., Rae B.C., Lai C.M. Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: a potential model for diabetic retinopathy. Diabetes 2003, 52:857-863.
313. Rangasamy S., Srinivasan R., Maestas J., McGuire P.G., Das A. A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2011, 52:3784-3791.
314. Rao N.A. Role of oxygen free radicals in retinal damage associated with experimental uveitis. Trans. Am. Ophthalmol. Soc. 1990, 88:797-850.
315. Rao N.A., Zhang J., Ishimoto S. Role of retinal vascular endothelial cells in development of CMV retinitis. Trans. Am. Ophthalmol. Soc. 1998, 96:111-123. discussion 124-116.
316. Rhodin J.A. The ultrastructure of mammalian arterioles and precapillary sphincters. J. Ultrastruct. Res. 1967, 18:181-223.
317. Rhodin J.A. Ultrastructure of mammalian venous capillaries, venules, and small collecting veins. J. Ultrastruct. Res. 1968, 25:452-500.
318. Rinderknecht E., Humbel R.E. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J. Biol. Chem. 1978, 253:2769-2776.
319. Roberts F., McLeod R. Pathogenesis of toxoplasmic retinochoroiditis. Parasitol. Today 1999, 15:51-57.
320. Rodriguez A., Calonge M., Pedroza-Seres M., Akova Y.A., Messmer E.M., D'Amico D.J., Foster C.S. Referral patterns of uveitis in a tertiary eye care center. Arch. Ophthalmol. 1996, 114:593-599.
321. Rot A., von Andrian U.H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 2004, 22:891-928.
322. Rothova A. Ocular involvement in toxoplasmosis. Br. J. Ophthalmol. 1993, 77:371-377.
323. Rothova A., Suttorp-van Schulten M.S., Frits Treffers W., Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br. J. Ophthalmol. 1996, 80:332-336.
324. Roy S., Ha J., Trudeau K., Beglova E. Vascular basement membrane thickening in diabetic retinopathy. Curr. Eye Res. 2010, 35:1045-1056.
325. Ruberte J., Ayuso E., Navarro M., Carretero A., Nacher V., Haurigot V., George M., Llombart C., Casellas A., Costa C., Bosch A., Bosch F. Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. J. Clin. Invest. 2004, 113:1149-1157.
326. Ruiz-Moreno J.M., Thillaye B., de Kozak Y. Retino-choroidal changes in endotoxin-induced uveitis in the rat. Ophthalmic Res. 1992, 24:162-168.
327. Rymaszewski Z., Szymanski P.T., Abplanalp W.A., Myatt L., Di Salvo J., Cohen R.M. Human retinal vascular cells differ from umbilical cells in synthetic functions and their response to glucose. Proc. Soc. Exp. Biol. Med. 1992, 199:183-191.
328. Rymo S.F., Gerhardt H., Wolfhagen Sand F., Lang R., Uv A., Betsholtz C. A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures. PLoS One 2011, 6:e15846.
329. Sallusto F., Lenig D., Mackay C.R., Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 1998, 187:875-883.
330. Sanders M.D., Graham E.M. Retinal vasculitis. Postgrad. Med. J. 1988, 64:488-496.
331. Santoni G., Spreghini E., Lucciarini R., Amantini C., Piccoli M. Involvement of alpha(v)beta3 integrin-like receptor and glycosaminoglycans in Candida albicans germ tube adhesion to vitronectin and to a human endothelial cell line. Microb. Pathog. 2001, 31:159-172.
332. Santoni V., Molloy M., Rabilloud T. Membrane proteins and proteomics: un amour impossible?. Electrophoresis 2000, 21:1054-1070.
333. Sanz L., Pascual M., Munoz A., Gonzalez M.A., Salvador C.H., Alvarez-Vallina L. Development of a computer-assisted high-throughput screening platform for anti-angiogenic testing. Microvasc. Res. 2002, 63:335-339.
334. Sapieha P., Joyal J.S., Rivera J.C., Kermorvant-Duchemin E., Sennlaub F., Hardy P., Lachapelle P., Chemtob S. Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J. Clin. Invest. 2010, 120:3022-3032.
335. Sapieha P., Sirinyan M., Hamel D., Zaniolo K., Joyal J.S., Cho J.H., Honore J.C., Kermorvant-Duchemin E., Varma D.R., Tremblay S., Leduc M., Rihakova L., Hardy P., Klein W.H., Mu X., Mamer O., Lachapelle P., Di Polo A., Beausejour C., Andelfinger G., Mitchell G., Sennlaub F., Chemtob S. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat. Med. 2008, 14:1067-1076.
336. Saraswathy S., Rao N.A. Mitochondrial proteomics in experimental autoimmune uveitis oxidative stress. Invest. Ophthalmol. Vis. Sci. 2009, 50:5559-5566.
337. Sari R.A., Kiziltunc A., Taysi S., Akdemir S., Gundogdu M. Levels of soluble E-selectin in patients with active Behcet's disease. Clin. Rheumatol. 2005, 24:55-59.
338. Schlie K., Spowart J.E., Hughson L.R., Townsend K.N., Lum J.J. When cells suffocate: autophagy in cancer and immune cells under low oxygen. Int. J. Cell Biol. 2011, 2011:470597.
339. Schnittler H., Preissner K.T. Between microbial attack and defence: the endothelium as a vulnerable player in infectious diseases. Thromb. Haemost. 2009, 102:1011-1013.
340. Schnittler H.J., Preissner K.T. Vascular endothelium and infectious diseases: trick and treat. Thromb. Haemost. 2005, 94:238-239.
341. Servat J.J., Mears K.A., Black E.H., Huang J.J. Biological agents for the treatment of uveitis. Expert Opin. Biol. Ther. 2012, 12:311-328.
342. Sfikakis P.P. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr. Dir. Autoimmun. 2010, 11:180-210.
343. Shaw L.C., Grant M.B. Insulin like growth factor-1 and insulin-like growth factor binding proteins: their possible roles in both maintaining normal retinal vascular function and in promoting retinal pathology. Rev. Endocr. Metab. Disord. 2004, 5:199-207.
344. Shaw L.C., Pan H., Afzal A., Calzi S.L., Spoerri P.E., Sullivan S.M., Grant M.B. Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization. Gene Ther. 2006, 13:752-760.
345. Shen W.Y., Lai C.M., Graham C.E., Binz N., Lai Y.K., Eade J., Guidolin D., Ribatti D., Dunlop S.A., Rakoczy P.E. Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model. Diabetologia 2006, 49:1690-1701.
346. Shi G., Cox C.A., Vistica B.P., Tan C., Wawrousek E.F., Gery I. Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells. J. Immunol. 2008, 181:7205-7213.
347. Shie J.L., Wu G., Wu J., Liu F.F., Laham R.J., Oettgen P., Li J. RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells. J. Biol. Chem. 2004, 279:25010-25016.
348. Shin D., Garcia-Cardena G., Hayashi S., Gerety S., Asahara T., Stavrakis G., Isner J., Folkman J., Gimbrone M.A., Anderson D.J. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev. Biol. 2001, 230:139-150.
349. Shinohara M., Masuyama T., Shoda T., Takahashi T., Katsuda Y., Komeda K., Kuroki M., Kakehashi A., Kanazawa Y. A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. Int. J. Exp. Diabetes Res. 2000, 1:89-100.
350. Silacci P., Mazzolai L., Gauci C., Stergiopulos N., Yin H.L., Hayoz D. Gelsolin superfamily proteins: key regulators of cellular functions. Cell. Mol. Life Sci. 2004, 61:2614-2623.
351. Silveira C., Vallochi A.L., Rodrigues da Silva U., Muccioli C., Holland G.N., Nussenblatt R.B., Belfort R., Rizzo L.V. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br. J. Ophthalmol. 2011, 95:396-400.
352. Silver P.B., Tarrant T.K., Chan C.C., Wiggert B., Caspi R.R. Mice deficient in inducible nitric oxide synthase are susceptible to experimental autoimmune uveoretinitis. Invest. Ophthalmol. Vis. Sci. 1999, 40:1280-1284.
353. Silverman M.D., Zamora D.O., Pan Y., Texeira P.V., Baek S.H., Planck S.R., Rosenbaum J.T. Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells. Invest. Ophthalmol. Vis. Sci. 2003, 44:1608-1615.
354. Sima A.A., Chakrabarti S., Garcia-Salinas R., Basu P.K. The BB-rat-an authentic model of human diabetic retinopathy. Curr. Eye Res. 1985, 4:1087-1092.
355. Singh S.P., Zhang H.H., Foley J.F., Hedrick M.N., Farber J.M. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J. Immunol. 2008, 180:214-221.
356. Sivakumar V., Zhang Y., Ling E.A., Foulds W.S., Kaur C. Insulin-like growth factors, angiopoietin-2, and pigment epithelium-derived growth factor in the hypoxic retina. J. Neurosci. Res. 2008, 86:702-711.
357. Smith J.R., Choi D., Chipps T.J., Pan Y., Zamora D.O., Davies M.H., Babra B., Powers M.R., Planck S.R., Rosenbaum J.T. Unique gene expression profiles of donor-matched human retinal and choroidal vascular endothelial cells. Invest. Ophthalmol. Vis. Sci. 2007, 48:2676-2684.
358. Smith J.R., Franc D.T., Carter N.S., Zamora D., Planck S.R., Rosenbaum J.T. Susceptibility of retinal vascular endothelium to infection with Toxoplasma gondii tachyzoites. Invest. Ophthalmol. Vis. Sci. 2004, 45:1157-1161.
359. Smith J.R., O'Rourke L.M., Becker M.D., Cao M., Williams K.A., Planck S.R., Rosenbaum J.T. Anti-rat ICAM-1 antibody does not influence the course of experimental melanin-induced uveitis. Curr. Eye Res. 2000, 21:906-912.
360. Smith L.E., Shen W., Perruzzi C., Soker S., Kinose F., Xu X., Robinson G., Driver S., Bischoff J., Zhang B., Schaeffer J.M., Senger D.R. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat. Med. 1999, 5:1390-1395.
361. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R., D'Amore P.A. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 1994, 35:101-111.
362. Smolenski R.T., Khalpey Z., Osborne F.N., Yuen A., Slominska E.M., Lipinski M., Lavitrano M., Rose M., Yacoub M.H. Species differences of endothelial extracellular nucleotide metabolism and its implications for xenotransplantation. Pharmacol. Rep. 2006, (58 Suppl.):118-125.
363. Song J., Guo X., Xie X., Zhao X., Li D., Deng W., Song Y., Shen F., Wu M., Wei L. Autophagy in hypoxia protects cancer cells against apoptosis induced by nutrient deprivation through a Beclin1-dependent way in hepatocellular carcinoma. J. Cell. Biochem. 2011, 112:3406-3420.
364. Soroceanu L., Akhavan A., Cobbs C.S. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 2008, 455:391-395.
365. Sosula L., Beaumont P., Hollows F.C., Jonson K.M. Dilatation and endothelial proliferation of retinal capillaries in streptozotocin-diabetic rats: quantitative electron microscopy. Invest. Ophthalmol. 1972, 11:926-935.
366. Spoerri P.E., Ellis E.A., Tarnuzzer R.W., Grant M.B. Insulin-like growth factor: receptor and binding proteins in human retinal endothelial cell cultures of diabetic and non-diabetic origin. Growth Horm. IGF Res.: Off. J. Growth Horm. Res. Soc. Int. IGF Res. Soc. 1998, 8:125-132.
367. Spranger J., Buhnen J., Jansen V., Krieg M., Meyer-Schwickerath R., Blum W.F., Schatz H., Pfeiffer A.F. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy. Horm. Metab. Res. 2000, 32:196-200.
368. Stahl A., Connor K.M., Sapieha P., Willett K.L., Krah N.M., Dennison R.J., Chen J., Guerin K.I., Smith L.E. Computer-aided quantification of retinal neovascularization. Angiogenesis 2009, 12:297-301.
369. Stamper H.B., Woodruff J.J. An in vitro model of lymphocyte homing. I. Characterization of the interaction between thoracic duct lymphocytes and specialized high-endothelial venules of lymph nodes. J. Immunol. 1977, 119:772-780.
370. Stanbury R.M., Graham E.M. Systemic corticosteroid therapy-side effects and their management. Br. J. Ophthalmol. 1998, 82:704-708.
371. Standring S. Gray's Anatomy: the Anatomical Basis of Clinical Practice 2008, Churchill Livingston Elsevier, Philadelphia. 40 ed.
372. Stanford M.R., See S.E., Jones L.V., Gilbert R.E. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology 2003, 110:926-931. quiz 931-922.
373. Steinle J.J., Granger H.J. Nerve growth factor regulates human choroidal, but not retinal, endothelial cell migration and proliferation. Auton. Neurosci. 2003, 108:57-62.
374. Stetler-Stevenson W.G. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest. 1999, 103:1237-1241.
375. Stewart E.A., Samaranayake G.J., Browning A.C., Hopkinson A., Amoaku W.M. Comparison of choroidal and retinal endothelial cells: characteristics and response to VEGF isoforms and anti-VEGF treatments. Exp. Eye Res. 2011, 93:761-766.
376. Stitt A.W. AGEs and diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2010, 51:4867-4874.
377. Stone J., Itin A., Alon T., Pe'er J., Gnessin H., Chan-Ling T., Keshet E. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 1995, 15:4738-4747.
378. Suhler E.B., Lloyd M.J., Choi D., Rosenbaum J.T., Austin D.F. Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific Northwest. Am. J. Ophthalmol. 2008, 146:890-896 e898.
379. Sun M., Yang Y., Yang P., Lei B., Du L., Kijlstra A. Regulatory effects of IFN-beta on the development of experimental autoimmune uveoretinitis in B10RIII mice. PLoS One 2011, 6:e19870.
380. Suttorp-Schulten M.S., Rothova A. The possible impact of uveitis in blindness: a literature survey. Br. J. Ophthalmol. 1996, 80:844-848.
381. Suzuma I., Mandai M., Suzuma K., Ishida K., Tojo S.J., Honda Y. Contribution of E-selectin to cellular infiltration during endotoxin-induced uveitis. Invest. Ophthalmol. Vis. Sci. 1998, 39:1620-1630.
382. Suzuma K., Takagi H., Otani A., Suzuma I., Honda Y. Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization. Microvasc. Res. 1998, 56:183-191.
383. Takagi H., King G.L., Ferrara N., Aiello L.P. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest. Ophthalmol. Vis. Sci. 1996, 37:1311-1321.
384. Takase H., Yu C.R., Liu X., Fujimoto C., Gery I., Egwuagu C.E. Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins. J. Neuroimmunol. 2005, 168:118-127.
385. Takeuchi A., Usui Y., Takeuchi M., Hattori T., Kezuka T., Suzuki J., Okunuki Y., Iwasaki T., Haino M., Matsushima K., Usui M. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response. Invest. Ophthalmol. Vis. Sci. 2005, 46:3753-3760.
386. Takizawa N., Ikebe R., Ikebe M., Luna E.J. Supervillin slows cell spreading by facilitating myosin II activation at the cell periphery. J. Cell. Sci. 2007, 120:3792-3803.
387. Takizawa N., Smith T.C., Nebl T., Crowley J.L., Palmieri S.J., Lifshitz L.M., Ehrhardt A.G., Hoffman L.M., Beckerle M.C., Luna E.J. Supervillin modulation of focal adhesions involving TRIP6/ZRP-1. J. Cell Biol. 2006, 174:447-458.
388. Tanaka K., Namba T., Arai Y., Fujimoto M., Adachi H., Sobue G., Takeuchi K., Nakai A., Mizushima T. Genetic evidence for a protective role for heat shock factor 1 and heat shock protein 70 against colitis. J. Biol. Chem. 2007, 282:23240-23252.
389. Tang J., Zhou R., Luger D., Zhu W., Silver P.B., Grajewski R.S., Su S.B., Chan C.C., Adorini L., Caspi R.R. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J. Immunol. 2009, 182:4624-4632.
390. Tarbell J.M., Ebong E.E. The endothelial glycocalyx: a mechano-sensor and -transducer. Sci. Signal. 2008, 1(Pt 8).
391. Tezel G., Li L.Y., Patil R.V., Wax M.B. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 2001, 42:1787-1794.
392. The Diabetic Retinopathy Study Research Group Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology 1981, 88:583-600.
393. Thillaye-Goldenberg B., Goureau O., Naud M.C., de Kozak Y. Delayed onset and decreased severity of experimental autoimmune uveoretinitis in mice lacking nitric oxide synthase type 2. J. Neuroimmunol. 2000, 110:31-44.
394. Tolentino M.J., Miller J.W., Gragoudas E.S., Jakobiec F.A., Flynn E., Chatzistefanou K., Ferrara N., Adamis A.P. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996, 103:1820-1828.
395. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5116-5121.
396. Uchio E., Kijima M., Tanaka S., Ohno S. Suppression of experimental uveitis with monoclonal antibodies to ICAM-1 and LFA-1. Invest. Ophthalmol. Vis. Sci. 1994, 35:2626-2631.
397. Ueta T., Yanagi Y., Tamaki Y., Yamaguchi T. Cerebrovascular accidents in ranibizumab. Ophthalmology 2009, 116:362.
398. Ulbig M.W., Wolfensberger T.J., Hiscott P., Ationu A., Carter N.D., Gregor Z.J. Insulin-like growth factor I (IGF-I) receptor/binding protein in human diabetic epiretinal membranes. Ger. J. Ophthalmol. 1995, 4:264-268.
399. Ulvmar M.H., Hub E., Rot A. Atypical chemokine receptors. Exp. Cell. Res. 2011, 317:556-568.
400. Umeda N., Ozaki H., Hayashi H., Miyajima-Uchida H., Oshima K. Colocalization of Tie2, angiopoietin 2 and vascular endothelial growth factor in fibrovascular membrane from patients with retinopathy of prematurity. Ophthalmic Res. 2003, 35:217-223.
401. van Wijngaarden P., Coster D.J., Williams K.A. Inhibitors of ocular neovascularization: promises and potential problems. JAMA 2005, 293:1509-1513.
402. Verity D.H., Wallace G.R., Seed P.T., Kanawati C.A., Ayesh I., Holland-Gladwish J., Stanford M.R. Soluble adhesion molecules in Behcet's disease. Ocul. Immunol. Inflamm. 1998, 6:81-92.
403. Vidro E.K., Gee S., Unda R., Ma J.X., Tsin A. Glucose and TGFbeta2 modulate the viability of cultured human retinal pericytes and their VEGF release. Curr. Eye Res. 2008, 33:984-993.
404. Vinores S.A., Xiao W.H., Aslam S., Shen J., Oshima Y., Nambu H., Liu H., Carmeliet P., Campochiaro P.A. Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development. J. Cell. Physiol. 2006, 206:749-758.
405. Virdi P.S., Hayreh S.S. Ocular neovascularization with retinal vascular occlusion. I. Association with experimental retinal vein occlusion. Arch. Ophthalmol. 1982, 100:331-341.
406. Wacker W.B., Lipton M.M. Experimental allergic uveitis: homologous retina as uveitogenic antigen. Nature 1965, 206:253-254.
407. Wakefield D., Lloyd A. The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine 1992, 4:1-5.
408. Wakui S., Yokoo K., Muto T., Suzuki Y., Takahashi H., Furusato M., Hano H., Endou H., Kanai Y. Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis. Laboratory investigation. J. Technical Methods Pathol. 2006, 86:1172-1184.
409. Wallace G.R., Whiston R.A., Stanford M.R., Wells G.M., Gearing A.J., Clements J.M. The matrix metalloproteinase inhibitor BB-1101 prevents experimental autoimmune uveoretinitis (EAU). Clin. Exp. Immunol. 1999, 118:364-370.
410. Wang H.U., Chen Z.F., Anderson D.J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 1998, 93:741-753.
411. Wang Y., Calder V.L., Lightman S.L., Greenwood J. Antigen presentation by rat brain and retinal endothelial cells. J. Neuroimmunol. 1995, 61:231-239.
412. Watanabe D., Suzuma K., Suzuma I., Ohashi H., Ojima T., Kurimoto M., Murakami T., Kimura T., Takagi H. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Am. J. Ophthalmol. 2005, 139:476-481.
413. Wheatley C.M., Dickinson J.L., Mackey D.A., Craig J.E., Sale M.M. Retinopathy of prematurity: recent advances in our understanding. Br. J. Ophthalmol. 2002, 86:696-700.
414. Whitcup S.M., Chan C.C., Li Q., Nussenblatt R.B. Expression of cell adhesion molecules in posterior uveitis. Arch. Ophthalmol. 1992, 110:662-666.
415. Whitcup S.M., DeBarge L.R., Caspi R.R., Harning R., Nussenblatt R.B., Chan C.C. Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis. Clin. Immunol. Immunopathol. 1993, 67:143-150.
416. Wilson S.H., Davis M.I., Caballero S., Grant M.B. Modulation of retinal endothelial cell behaviour by insulin-like growth factor I and somatostatin analogues: implications for diabetic retinopathy. Growth Horm. IGF Res.: Off. J. Growth Horm. Res. Soc. Int. IGF Res. Soc. 2001, (11 Suppl. A):S53-S59.
417. Wilson S.L., Drevets D.A. Listeria monocytogenes infection and activation of human brain microvascular endothelial cells. J. Infect. Dis. 1998, 178:1658-1666.
418. Witmer A.N., Blaauwgeers H.G., Weich H.A., Alitalo K., Vrensen G.F., Schlingemann R.O. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest. Ophthalmol. Vis. Sci. 2002, 43:849-857.
419. Wu C.C., MacCoss M.J. Shotgun proteomics: tools for the analysis of complex biological systems. Curr. Opin. Mol. Ther. 2002, 4:242-250.
420. Wu S.Y., Lan S.H., Cheng D.E., Chen W.K., Shen C.H., Lee Y.R., Zuchini R., Liu H.S. Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation. Neoplasia 2011, 13:1171-1182.
421. Wulfkuhle J.D., Donina I.E., Stark N.H., Pope R.K., Pestonjamasp K.N., Niswonger M.L., Luna E.J. Domain analysis of supervillin, an F-actin bundling plasma membrane protein with functional nuclear localization signals. J. Cell. Sci. 1999, 112(Pt 13):2125-2136.
422. Xu H., Dawson R., Crane I.J., Liversidge J. Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood-retina barrier. Invest. Ophthalmol. Vis. Sci. 2005, 46:2487-2494.
423. Xu H., Forrester J.V., Liversidge J., Crane I.J. Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules. Invest. Ophthalmol. Vis. Sci. 2003, 44:226-234.
424. Xu H., Koch P., Chen M., Lau A., Reid D.M., Forrester J.V. A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images. Exp. Eye Res. 2008, 87:319-326.
425. Xu H., Manivannan A., Goatman K.A., Jiang H.R., Liversidge J., Sharp P.F., Forrester J.V., Crane I.J. Reduction in shear stress, activation of the endothelium, and leukocyte priming are all required for leukocyte passage across the blood-retina barrier. J. Leukoc. Biol. 2004, 75:224-232.
426. Xu H., Manivannan A., Goatman K.A., Liversidge J., Sharp P.F., Forrester J.V., Crane I.J. Improved leukocyte tracking in mouse retinal and choroidal circulation. Exp. Eye Res. 2002, 74:403-410.
427. Xu H., Manivannan A., Jiang H.R., Liversidge J., Sharp P.F., Forrester J.V., Crane I.J. Recruitment of IFN-gamma-producing (Th1-like) cells into the inflamed retina in vivo is preferentially regulated by P-selectin glycoprotein ligand 1:P/E-selectin interactions. J. Immunol. 2004, 172:3215-3224.
428. Xu H., Manivannan A., Liversidge J., Sharp P.F., Forrester J.V., Crane I.J. Requirements for passage of T lymphocytes across non-inflamed retinal microvessels. J. Neuroimmunol. 2003, 142:47-57.
429. Xu M., Jin Y., Song Q., Wu J., Philbrick M.J., Cully B.L., An X., Guo L., Gao F., Li J. The endothelium-dependent effect of RTEF-1 in pressure overload cardiac hypertrophy: role of VEGF-B. Cardiovasc. Res. 2011, 90:325-334.
430. Yoshida T., Zhang H., Iwase T., Shen J., Semenza G.L., Campochiaro P.A. Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization. FASEB J. 2010, 24:1759-1767.
431. Yu C.R., Mahdi R.R., Oh H.M., Amadi-Obi A., Levy-Clarke G., Burton J., Eseonu A., Lee Y., Chan C.C., Egwuagu C.E. Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation. Invest. Ophthalmol. Vis. Sci. 2011, 52:6978-6986.
432. Yu P.K., Balaratnasingam C., Cringle S.J., McAllister I.L., Provis J., Yu D.Y. Microstructure and network organization of the microvasculature in the human macula. Invest. Ophthalmol. Vis. Sci. 2010, 51:6735-6743.
433. Yu P.K., Balaratnasingam C., Morgan W.H., Cringle S.J., McAllister I.L., Yu D.Y. The structural relationship between the microvasculature, neurons, and glia in the human retina. Invest. Ophthalmol. Vis. Sci. 2010, 51:447-458.
434. Yu P.K., Yu D., Alder V.A., Seydel U., Su E., Cringle S.J. Heterogeneous endothelial cell structure along the porcine retinal microvasculature. Exp. Eye Res. 1997, 65:379-389.
435. Yuan H.T., Khankin E.V., Karumanchi S.A., Parikh S.M. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol. Cell. Biol. 2009, 29:2011-2022.
436. Yuan W., Zhang J., Li S., Edwards J.L. Amine metabolomics of hyperglycemic endothelial cells using capillary LC-MS with isobaric tagging. J. Proteome Res. 2011, 10:5242-5250.
437. Zaman A.G., Edelsten C., Stanford M.R., Graham E.M., Ellis B.A., Direskeneli H., D'Cruz D.P., Hughes G.R., Dumonde D.C., Wallace G.R. Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis. Clin. Exp. Immunol. 1994, 95:60-65.
438. Zamora D.O., Rosenbaum J.T., Smith J.R. Invasion of human retinal vascular endothelial cells by Toxoplasma gondii tachyzoites. Br. J. Ophthalmol. 2008, 92:852-855.
439. Zanetti A., Conforti G., Hess S., Martin-Padura I., Ghibaudi E., Preissner K.T., Dejana E. Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membrane. Blood 1994, 84:1116-1123.
440. Zhang H., Sonoda K.H., Qiao H., Oshima T., Hisatomi T., Ishibashi T. Development of a new mouse model of branch retinal vein occlusion and retinal neovascularization. Jpn. J. Ophthalmol. 2007, 51:251-257.
441. Zhang H.R. Scanning electron-microscopic study of corrosion casts on retinal and choroidal angioarchitecture in man and animals. Prog. Retin. Eye Res. 1994, 13:243-270.
442. Zhang J., Wu L.Y., Wu G.S., Rao N.A. Differential expression of nitric oxide synthase in experimental uveoretinitis. Invest. Ophthalmol. Vis. Sci. 1999, 40:1899-1905.
443. Zhang L.Q., Cheranova D., Gibson M., Ding S., Heruth D.P., Fang D., Ye S.Q. RNA-seq reveals novel transcriptome of genes and their isoforms in human pulmonary microvascular endothelial cells treated with thrombin. PLoS One 2012, 7:e31229.
444. Zhang Y., Fortune B., Atchaneeyasakul L.O., McFarland T., Mose K., Wallace P., Main J., Wilson D., Appukuttan B., Stout J.T. Natural history and histology in a rat model of laser-induced photothrombotic retinal vein occlusion. Curr. Eye Res. 2008, 33:365-376.
445. Zhao M., Bousquet E., Valamanesh F., Farman N., Jeanny J.C., Jaisser F., Behar-Cohen F.F. Differential regulations of AQP4 and Kir4.1 by triamcinolone acetonide and dexamethasone in the healthy and inflamed retina. Invest. Ophthalmol. Vis. Sci. 2011, 52:6340-6347.
446. Zhou Q., Wong W.H. CisModule: de novo discovery of cis-regulatory modules by hierarchical mixture modeling. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:12114-12119.
447. Zou Y., He L., Huang S.H. Identification of a surface protein on human brain microvascular endothelial cells as vimentin interacting with Escherichia coli invasion protein IbeA. Biochem. Biophys. Res. Commun. 2006, 351:625-630.